Quick Answer
MIMEDX GROUP, INC. reported Research And Development Expense of $15.10 million for the year ending 2025.
- MIMEDX GROUP, INC. showed an increase of +22.3% in Research And Development Expense from 2024 to 2025.
- This data is from MIMEDX GROUP, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), MIMEDX GROUP, INC.'s Research And Development Expense has grown by 448.3%.
- Historical annual values: Fiscal year 2025: $15.10 million | Fiscal year 2024: $12.34 million | Fiscal year 2023: $12.67 million | Fiscal year 2022: $12.70 million | Fiscal year 2021: $9.93 million | Fiscal year 2020: $11.72 million | Fiscal year 2019: $11.14 million | Fiscal year 2018: $15.77 million | Fiscal year 2017: $17.90 million | Fiscal year 2016: $14.34 million | Fiscal year 2015: $8.41 million | Fiscal year 2014: $7.05 million | Fiscal year 2013: $4.84 million | Fiscal year 2012: $2.89 million | Fiscal year 2011: $2.98 million | Fiscal year 2010: $2.75 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: